506 related articles for article (PubMed ID: 34753372)
1. Perspectives of metformin use in endometrial cancer and other gynaecological malignancies.
Barczyński B; Frąszczak K; Kotarski J
J Drug Target; 2022 Apr; 30(4):359-367. PubMed ID: 34753372
[TBL] [Abstract][Full Text] [Related]
2. Metformin in selected malignancies in women.
Markowska A; Stanislawiak-Rudowicz J; Kasprzak T; Markowska J; Szarszewska M
Ginekol Pol; 2022; 93(5):416-421. PubMed ID: 35072253
[TBL] [Abstract][Full Text] [Related]
3. Metformin in reproductive health, pregnancy and gynaecological cancer: established and emerging indications.
Sivalingam VN; Myers J; Nicholas S; Balen AH; Crosbie EJ
Hum Reprod Update; 2014; 20(6):853-68. PubMed ID: 25013215
[TBL] [Abstract][Full Text] [Related]
4. [Molecular action of insulin-sensitizing agents].
Kacalska O; Krzyczkowska-Sendrakowska M; Milewicz T; Zabińska-Popiela M; Bereza T; Krzysiek-Maczka G; Krzysiek J
Endokrynol Pol; 2005; 56(3):308-13. PubMed ID: 16350724
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of midkine by metformin can contribute to its anticancer effects in malignancies: A proposal mechanism of action of metformin in context of endometrial cancer prevention and therapy.
Karadeniz Z; Aynacıoğlu AŞ; Bilir A; Tuna MY
Med Hypotheses; 2020 Jan; 134():109420. PubMed ID: 31634770
[TBL] [Abstract][Full Text] [Related]
6. Insulin-Like Growth Factor 1/Mammalian Target of Rapamycin and AMP-Activated Protein Kinase Signaling Involved in the Effects of Metformin in the Human Endometrial Cancer.
Cai D; Sun H; Qi Y; Zhao X; Feng M; Wu X
Int J Gynecol Cancer; 2016 Nov; 26(9):1667-1672. PubMed ID: 27654259
[TBL] [Abstract][Full Text] [Related]
7. New therapeutic approaches for the fertility-sparing treatment of endometrial cancer.
Mitsuhashi A; Shozu M
J Obstet Gynaecol Res; 2020 Feb; 46(2):215-222. PubMed ID: 32017321
[TBL] [Abstract][Full Text] [Related]
8. Changes in protein expression due to metformin treatment and hyperinsulinemia in a human endometrial cancer cell line.
Lange C; Machado Weber A; Schmidt R; Schroeder C; Strowitzki T; Germeyer A
PLoS One; 2021; 16(3):e0248103. PubMed ID: 33690729
[TBL] [Abstract][Full Text] [Related]
9. Metformin use and gynecological cancers: A novel treatment option emerging from drug repositioning.
Gadducci A; Biglia N; Tana R; Cosio S; Gallo M
Crit Rev Oncol Hematol; 2016 Sep; 105():73-83. PubMed ID: 27378194
[TBL] [Abstract][Full Text] [Related]
10. Systematic review and meta-analysis of the effect of metformin treatment on overall mortality rates in women with endometrial cancer and type 2 diabetes mellitus.
Perez-Lopez FR; Pasupuleti V; Gianuzzi X; Palma-Ardiles G; Hernandez-Fernandez W; Hernandez AV
Maturitas; 2017 Jul; 101():6-11. PubMed ID: 28539171
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of metformin in the treatment of estrogen-dependent endometrial carcinoma complicated with type 2 diabetes mellitus and analysis of its prognosis.
Deng Y; Wang J; Li W; Xiong W; Wang X
J BUON; 2020; 25(3):1534-1540. PubMed ID: 32862601
[TBL] [Abstract][Full Text] [Related]
12. Effects of metformin on endometrial cancer cell growth in vivo: a preoperative prospective trial.
Mitsuhashi A; Kiyokawa T; Sato Y; Shozu M
Cancer; 2014 Oct; 120(19):2986-95. PubMed ID: 24917306
[TBL] [Abstract][Full Text] [Related]
13. Metformin in cancer.
Mallik R; Chowdhury TA
Diabetes Res Clin Pract; 2018 Sep; 143():409-419. PubMed ID: 29807101
[TBL] [Abstract][Full Text] [Related]
14. [Metformin--new treatment strategies for gynecologic neoplasms].
Milewicz T; Kiałka M; Mrozińska S; Ociepka A; Krzysiek J
Przegl Lek; 2013; 70(2):81-4. PubMed ID: 23879009
[TBL] [Abstract][Full Text] [Related]
15. Do endometrial cancer patients benefit from metformin intake?
Lemańska A; Zaborowski M; Spaczyński M; Nowak-Markwitz E
Ginekol Pol; 2015 Jun; 86(6):419-23. PubMed ID: 26255448
[TBL] [Abstract][Full Text] [Related]
16. Mechanism and application of metformin in kidney diseases: An update.
Song A; Zhang C; Meng X
Biomed Pharmacother; 2021 Jun; 138():111454. PubMed ID: 33714781
[TBL] [Abstract][Full Text] [Related]
17. Anticancer effects of metformin and its potential use as a therapeutic agent for breast cancer.
Guppy A; Jamal-Hanjani M; Pickering L
Future Oncol; 2011 Jun; 7(6):727-36. PubMed ID: 21675836
[TBL] [Abstract][Full Text] [Related]
18. Medroxyprogesterone acetate plus metformin for fertility-sparing treatment of atypical endometrial hyperplasia and endometrial carcinoma: trial protocol for a prospective, randomised, open, blinded-endpoint design, dose-response trial (FELICIA trial).
Mitsuhashi A; Kawasaki Y; Hori M; Fujiwara T; Hanaoka H; Shozu M
BMJ Open; 2020 Feb; 10(2):e035416. PubMed ID: 32114477
[TBL] [Abstract][Full Text] [Related]
19. The prognostic role of metformin in patients with endometrial cancer: a retrospective study.
Seebacher V; Bergmeister B; Grimm C; Koelbl H; Reinthaller A; Polterauer S
Eur J Obstet Gynecol Reprod Biol; 2016 Aug; 203():291-6. PubMed ID: 27423029
[TBL] [Abstract][Full Text] [Related]
20. Metformin and survival: Is there benefit in a cohort limited to diabetic women with endometrial, breast, or ovarian cancer?
Lemon LS; Orr B; Modugno F; Buckanovich RJ; Coffman L; Edwards RP; Taylor S
Gynecol Oncol; 2022 Apr; 165(1):60-66. PubMed ID: 35140015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
